Cronos Group Inc.

CRON ·Healthcare, Drug Manufacturers - General, Ontario, Canada
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017
Revenue $3.1M
Cost of Revenue —
Gross Profit $1.6M
Gross Margin 50.0%
Operating Expenses
Research & Development $0
SG&A Expense $4.9M
Operating Income $-6.1M
Operating Margin -194.5%
Interest Expense $101.0K
Pretax Income $-2.3M
Income Tax Expense $-862.0K
Net Income $-1.5M
Net Margin -47.1%
EPS (Basic) $-0.01
EPS (Diluted) $-0.01
Shares Outstanding (Basic) 134.8M
Shares Outstanding (Diluted) 176.8M
Dividends Per Share —
← Newer Page 2 of 2 Older →